View Older Stories View More Recent Stories

Oct 28, 2020 04:09PM Forte Biosciences Announces Proposed Public Offering of Common Stock
Oct 27, 2020 02:20PM Mallard Acquisition Corp. Announces Pricing of $110 Million Initial Public Offering
Oct 27, 2020 07:57AM Chardan Capital Markets Starts Axcella Health Inc. (AXLA) at Buy, $16 PT; 'Simplified Approach to Improving Metabolic Health'
Oct 27, 2020 07:25AM UPDATE: Chardan Capital Markets Starts Immunome Inc. (IMNM) at Buy, Bullish on Antibody Discovery Platform
Oct 22, 2020 02:00AM Longevity Acquisition Corporation Announces Signing of Definitive Merger Agreement
Oct 22, 2020 12:30AM Gensight Biologics Successfully Raises €25 Million in an Oversubscribed Private Placement With Us and European Institutional Investors
Oct 19, 2020 09:41AM Chardan Capital Markets Starts Taysha Gene Therapies (TSHA) at Buy
Oct 15, 2020 07:00AM Hudson Capital Inc. Enters into Definitive Merger Agreement with FreightHub, Inc., a North American Digital Transportation Logistics Platform Company with a Focus on US-Mexico Cross-Border Shipping
Oct 13, 2020 04:05PM Immunome Announces Exercise in Full and Closing of Over-Allotment Option in Initial Public Offering
Oct 6, 2020 08:38AM Iovanace Biotherapeutics (IOVA) PT Lowered to $50 at Chardan Capital Markets on Delay
Oct 5, 2020 04:05PM Oncorus to Present at Chardan 4th Annual Genetic Medicines Conference
Oct 5, 2020 04:05PM Oncorus to Present at Chardan 4th Annual Genetic Medicines Conference
Oct 5, 2020 11:12AM LogicBio Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oct 5, 2020 11:12AM LogicBio Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oct 5, 2020 09:00AM CARISMA Therapeutics to Participate in Upcoming Investor Conferences
Oct 5, 2020 08:00AM OncoMyx to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference
Oct 5, 2020 07:00AM Exicure to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference
Oct 5, 2020 07:00AM Axovant to Participate in Upcoming October Conferences and Provide AXO-Lenti-PD Program Update the Morning of October 6th
Oct 2, 2020 11:42AM Immunome (IMNM) IPO Opens 31% Higher
Oct 2, 2020 08:00AM Beam Therapeutics to Participate in Chardan Virtual 4th Annual Genetic Medicines Conference
Oct 2, 2020 08:00AM Beam Therapeutics to Participate in Chardan Virtual 4th Annual Genetic Medicines Conference
Oct 2, 2020 07:30AM Solid Biosciences to Participate in Virtual Fireside Chat at the Chardan 4th Annual Genetic Medicines Conference
Oct 2, 2020 06:03AM Immunome Inc. (IMNM) Prices 3.25M Share Upsized IPO at $12/Sh
Oct 1, 2020 08:23PM Immunome Announces Pricing of Upsized Initial Public Offering
Oct 1, 2020 10:55AM Solid Biosciences (SLDB) PT Raised to $12.50 at Chardan Capital Markets
Oct 1, 2020 09:12AM LogicBio Therapeutics (LOGC) Prices 7M Share Public Offering of Common Stock at $6/Each
Oct 1, 2020 09:10AM LogicBio Therapeutics Announces Pricing of Public Offering of Common Stock
Oct 1, 2020 09:09AM LogicBio Therapeutics Announces Pricing of Public Offering of Common Stock
Oct 1, 2020 08:30AM Mustang Bio to Participate in Chardan’s Virtual 4th Annual Genetic Medicines Conference 2020
Oct 1, 2020 08:30AM Mustang Bio to Participate in Chardan’s Virtual 4th Annual Genetic Medicines Conference 2020
Oct 1, 2020 08:00AM Editas Medicine to Participate in Upcoming Investor Conference
Oct 1, 2020 08:00AM Editas Medicine to Participate in Upcoming Investor Conference
Oct 1, 2020 07:33AM Diginex Lists and Begins Trading on Nasdaq
Oct 1, 2020 07:00AM Silence Therapeutics to Participate in the Chardan Virtual 4th Annual Genetic Medicines Conference
Oct 1, 2020 07:00AM Replimune to Participate at the Chardan Virtual 4th Annual Genetic Medicines Conference
Oct 1, 2020 01:30AM Sensorion Announces Attendance and Presentations at Upcoming Conferences
Sep 30, 2020 04:02PM LogicBio Therapeutics (LOGC) Announces Proposed Common Offering
Sep 30, 2020 04:01PM LogicBio Therapeutics Announces Proposed Public Offering of Common Stock
Sep 30, 2020 04:01PM Arrowhead Pharmaceuticals to Participate in Upcoming Investor Conference
Sep 30, 2020 04:01PM LogicBio Therapeutics Announces Proposed Public Offering of Common Stock
Sep 30, 2020 08:51AM Genenta to present preliminary Phase I/II clinical data on Temferon™ in glioblastoma multiforme at Chardan’s 4th Annual Genetic Medicines Conference
Sep 30, 2020 07:05AM uniQure to Participate in Multiple Upcoming Industry Conferences in October
Sep 29, 2020 04:05PM Translate Bio to Participate in Upcoming Investor Conferences
Sep 29, 2020 09:25AM Taysha Gene Therapies Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Sep 29, 2020 08:00AM CRISPR Therapeutics to Participate in Upcoming Investor Conferences
Sep 29, 2020 08:00AM VBL Therapeutics to Present at the Chardan 4th Annual Genetic Medicines Conference
Sep 29, 2020 07:35AM Ocugen to Participate in a Virtual Fireside Chat at the Chardan Genetic Medicines Conference
Sep 29, 2020 07:00AM Freeline to participate in Chardan’s 4th Annual Genetic Medicines Conference at the revised time of 3.45 pm EDT on 6 October
Sep 29, 2020 07:00AM Tmunity to Present at Upcoming Investor Conferences
Sep 29, 2020 07:00AM Freeline to participate in Chardan’s 4th Annual Genetic Medicines Conference at the revised time of 3.45 pm EDT on 6 October
View More Recent Stories View Older Stories